FDA inspection
Syngene International Ltd.: FDA inspection ending Feb 20, 2025
FDA inspection 1267516 · Voluntary Action Indicated (VAI) · Bengaluru
Key facts
| Inspection ID | 1267516 |
|---|---|
| Firm | Syngene International Ltd. |
| FEI number | 3003600340 |
| Address | Biocon Sez, Biocon Park, Plot No. 2, 3, 4 & 5, Bommasandra Industrial Park, Jigani Link Road |
| City | Bengaluru |
| Country | India |
| Fiscal year | 2025 |
| Inspection end date | Feb 20, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data